Stereoselective pharmacokinetics of ifosfamide in male and female rats

AAPS pharmSci

Volumn 2, Issue 2, 2000, Pages 98-

  Wang, Jeff J ^a   Lu, Hong ^a,c   Chan, Kenneth K ^b,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; IFOSFAMIDE; PLASMA PROTEIN;

ANIMAL; ARTICLE; BLOOD; ERYTHROCYTE; FEMALE; IN VITRO STUDY; LIVER MICROSOME; MALE; MASS FRAGMENTOGRAPHY; METABOLISM; PLASMA; PROTEIN BINDING; RAT; RAT STRAIN; SEX DIFFERENCE; STEREOISOMERISM;

ANIMAL; ANTINEOPLASTIC AGENTS, ALKYLATING; BLOOD PROTEINS; ERYTHROCYTES; FEMALE; IFOSFAMIDE; IN VITRO; MALE; MASS FRAGMENTOGRAPHY; MICROSOMES, LIVER; PLASMA; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; STEREOISOMERISM;

EID: 18044401100     PISSN: None     EISSN: 15221059     Source Type: Journal    
DOI: 10.1208/ps020217     Document Type: Article

References (32)

1. 1. Dollery SC. Ifosfamide. In: Dollery SC, ed. Therapeutic Drugs. Churchill Livingstone, 1991: 110–115.
2. 2. T. Wagner 1994 Ifosfamide clinical pharmacokinetics Clin Pharmacokinet 26 439 456 1:CAS:528:DyaK2cXlvFCksLw%3D 8070218 10.2165/00003088-199426060-00003 Wagner T. Ifosfamide clinical pharmacokinetics. Clin Pharmacokinet. 1994; 26: 439–456.
3. 3. JH Wang KK Chan 1995 Identification of new metabolites of ifosfamide in rat urine using ion cluster technique J Mass Spectrom 30 675 683 1:CAS:528:DyaK2MXlvFams74%3D 10.1002/jms.1190300504 Wang JH, Chan KK. Identification of new metabolites of ifosfamide in rat urine using ion cluster technique. J Mass Spectrom. 1995; 30: 675–683.
4. 4. IW Wainer CP Granville T Wang G Batist 1994 Efficacy and toxicity of ifosfamide stereoisomers in an in vivo rat mammary carcinoma model Cancer Res 54 4393 4397 1:CAS:528:DyaK2cXls12qu7k%3D 8044787 Wainer IW, Granville CP, Wang T, Batist G. Efficacy and toxicity of ifosfamide stereoisomers in an in vivo rat mammary carcinoma model. Cancer Res. 1994; 54: 4393–4397.
5. 5. IW Wainer J Ducharme CP Granvil M Trudeau B Leyland-Jones 1994 Ifosfamide stereoselective dechloroethylation and neurotoxicity Lancet 343 982 983 1:STN:280:DyaK2c3htFSjsg%3D%3D 7909040 10.1016/S0140-6736(94)90109-0 Wainer IW, Ducharme J, Granvil CP, Trudeau M, Leyland-Jones B. Ifosfamide stereoselective dechloroethylation and neurotoxicity. Lancet. 1994; 343: 982–983.
6. 6. PB Farmer 1988 Enantiomers of cyclophosphamide and iphosphamide Biochem Pharmacol 37 145 148 1:CAS:528:DyaL1cXmvVWjuw%3D%3D 3337735 10.1016/0006-2952(88)90767-8 Farmer PB. Enantiomers of cyclophosphamide and iphosphamide. Biochem Pharmacol. 1988; 37: 145–148.
7. 7. K Misiura A Okruszek K Pankiewick WK Stec Z Czownicki B Utracka 1983 Stereospecific synthesis of chiral metabolites of ifosfamide and their determination of the urine J Med Chem 26 474 679 10.1021/jm00359a010 Misiura K, Okruszek A, Pankiewick K, Stec WK, Czownicki Z, Utracka B. Stereospecific synthesis of chiral metabolites of ifosfamide and their determination of the urine. J Med Chem. 1983; 26: 474–679.
8. 8. J Boss U Welslau J Ritter G Blaschke G Schellong 1991 Urinary excretion of the enantiomers of ifosfamide and its inactive metabolite in children Cancer Chemother Pharmacol 28 455 460 10.1007/BF00685822 Boss J, Welslau U, Ritter J, Blaschke G, Schellong G. Urinary excretion of the enantiomers of ifosfamide and its inactive metabolite in children. Cancer Chemother Pharmacol. 1991; 28: 455–460.
9. 9. CP Granville B Gehrcke WA Konig IW Wainer 1993 Determination of the enantiomers of ifosfamide and its 2-and 3-N-dechloroethylated metabolites in plasma and urine using enantioselective gas chromatography with mass spectrometric detection J Chromatogr 622 21 31 1:CAS:528:DyaK2cXpsVGrsg%3D%3D 8120109 10.1016/0378-4347(93)80245-Y Granville CP, Gehrcke B, Konig WA, Wainer IW. Determination of the enantiomers of ifosfamide and its 2-and 3-N-dechloroethylated metabolites in plasma and urine using enantioselective gas chromatography with mass spectrometric detection. J Chromatogr. 1993; 622: 21–31.
10. 10. VK Prasad SA Corlett K Abaasi D Heney I Lewis H Chrystyn 1994 Ifosfamide enantiomers: pharmacokinetics in children Cancer Chemother Pharmacol 34 447 449 1:STN:280:DyaK2czkvFCqsg%3D%3D 8070015 10.1007/BF00685573 Prasad VK, Corlett SA, Abaasi K, Heney D, Lewis I, Chrystyn H. Ifosfamide enantiomers: pharmacokinetics in children. Cancer Chemother Pharmacol. 1994; 34: 447–449.
11. 11. SA Corlett D Parker H Chrystyn 1995 Pharmacokinetics of ifosfamide and its enantiomers following a single 1 h intravenous infusion of the racemate in patients with small cell lung carcinoma Br J Clin Pharmac 39 452 455 1:STN:280:DyaK2MzmslChsw%3D%3D 10.1111/j.1365-2125.1995.tb04477.x Corlett SA, Parker D, Chrystyn H. Pharmacokinetics of ifosfamide and its enantiomers following a single 1 h intravenous infusion of the racemate in patients with small cell lung carcinoma. Br J Clin Pharmac. 1995; 39: 452–455.
12. 12. EJD Lee KM Williams 1990 Chirality clinical pharmacokinetic and pharmacodynamic considerations Clin Pharmacokinet. 18 339 345 1:CAS:528:DyaK3cXkslSnur4%3D 2185905 10.2165/00003088-199018050-00001 Lee EJD, Williams KM. Chirality clinical pharmacokinetic and pharmacodynamic considerations. Clin Pharmacokinet. 1990; 18: 339–345.
13. 13. KM Williams EJD Lee 1985 Importance of drug enantiomers in clinical pharmacology Drugs 30 333 354 1:CAS:528:DyaL2MXlslWgsrs%3D 3905334 10.2165/00003495-198530040-00003 Williams KM, Lee EJD. Importance of drug enantiomers in clinical pharmacology. Drugs. 1985; 30: 333–354.
14. 14. F Jamali R Mehvar FM Pasutto 1989 Enantioselective aspects of drug action and disposition: therapeutic pitfalls J Pharm Sci 78 695 715 1:CAS:528:DyaL1MXlvVKktLo%3D 2685226 10.1002/jps.2600780902 Jamali F, Mehvar R, Pasutto FM. Enantioselective aspects of drug action and disposition: therapeutic pitfalls. J Pharm Sci. 1989; 78: 695–715.
15. 15. C P Granvil T Wang G Batist IW Wainer 1994 Influence of phenobarbital induction on the enantioselective N-dechloroethylation of ifosfamide enantiomers in the rat Drug Metab Dispos 22 165 167 1:CAS:528:DyaK2cXhvVagsrs%3D 8149878 Granvil C P, Wang T, Batist G, Wainer IW. Influence of phenobarbital induction on the enantioselective N-dechloroethylation of ifosfamide enantiomers in the rat. Drug Metab Dispos. 1994; 22: 165–167.
16. 16. IW Wainer J Ducharme CP Granville 1996 The N-dechloroethylation of ifosfamide: using stereochemistry to obtain an accurate picture of a clinically relevant metabolic pathway Cancer Chemother Pharmacol 37 332 336 1:CAS:528:DyaK28Xhs1ShtL4%3D 8548878 10.1007/s002800050393 Wainer IW, Ducharme J, Granville CP. The N-dechloroethylation of ifosfamide: using stereochemistry to obtain an accurate picture of a clinically relevant metabolic pathway. Cancer Chemother Pharmacol. 1996; 37: 332–336.
17. 17. CP Granville J Ducharme BL Jones M Trudean IW Wainer 1996 Stereoselective pharmacokinetics of ifosfamide and its 2-and 3-N-dechloroethylated metabolites in female cancer patients Cancer Chemother Pharmacol 37 451 456 10.1007/s002800050411 Granville CP, Ducharme J, Jones BL, Trudean M, Wainer IW. Stereoselective pharmacokinetics of ifosfamide and its 2-and 3-N-dechloroethylated metabolites in female cancer patients. Cancer Chemother Pharmacol. 1996; 37: 451–456.
18. 18. CP Granville A Madan M Sharkawi A Parkinson IW Wainer 1999 Role of CYP2B6 and CYP3A4 in the in vitro N-dechloroethylation of (R)-and (S)-ifosfamide in human liver microsomes Drug Metab Disp 27 533 541 Granville CP, Madan A, Sharkawi M, Parkinson A, Wainer IW. Role of CYP2B6 and CYP3A4 in the in vitro N-dechloroethylation of (R)-and (S)-ifosfamide in human liver microsomes. Drug Metab Disp. 1999; 27: 533–541.
19. 19. MP Ducharme ML Berstein CP Granvil B Gehrcke IW Wainer 1997 Phenytoin-induced alteration in the N-dechloroethylation of ifosfamide stereoisomers Cancer Chemother Pharmacol 40 531 533 1:STN:280:DyaK2svntlKitw%3D%3D 9332469 10.1007/s002800050698 Ducharme MP, Berstein ML, Granvil CP, Gehrcke B, Wainer IW. Phenytoin-induced alteration in the N-dechloroethylation of ifosfamide stereoisomers. Cancer Chemother Pharmacol. 1997; 40: 531–533.
20. 20. MP Goren RK Wright CB Pratt PE Pell 1986 Dechloroethylation of ifosfamide and neurotoxicity Lancet. 2 1219 1220 1:STN:280:DyaL2s%2FjvVGjug%3D%3D 2877353 10.1016/S0140-6736(86)92227-0 Goren MP, Wright RK, Pratt CB, Pell PE. Dechloroethylation of ifosfamide and neurotoxicity. Lancet. 1986; 2: 1219–1220.
21. 21. L Hong JJ Wang KK Chan D Young 1998 Effect of phenobarbital on stereoselective metabolism of ifosfamide in rats Drug Metab Disp 26 476 482 Hong L, Wang JJ, Chan KK, Young D. Effect of phenobarbital on stereoselective metabolism of ifosfamide in rats. Drug Metab Disp. 1998; 26: 476–482.
22. 22. JJ-H Wang KK Chan 1996 Stereospecific synthesis of tretradeuterated (R-and (S)-ifosfamide J Labelled Compd 38 105 115 1:CAS:528:DyaK28XnvVagtA%3D%3D 10.1002/(SICI)1099-1344(199602)38:2<105::AID-JLCR821>3.0.CO;2-X Wang JJ-H, Chan KK. Stereospecific synthesis of tretradeuterated (R-and (S)-ifosfamide. J Labelled Compd. 1996; 38: 105–115.
23. 23. JJ-H Wang KK Chan 1995 Analysis of ifosfamide, 4-hydroxyifosfamide, N 2-dechloroethylifosfamide, N 3-dechloroethylifosfamide, and iphosphoramide mustard in plasma by gas chromatographic-mass spectrometry J Chromatogr B 674 205 217 1:CAS:528:DyaK2MXhtVSgt77N 10.1016/0378-4347(95)00309-6 Wang JJ-H, Chan KK. Analysis of ifosfamide, 4-hydroxyifosfamide, N 2-dechloroethylifosfamide, N 3-dechloroethylifosfamide, and iphosphoramide mustard in plasma by gas chromatographic-mass spectrometry. J Chromatogr B. 1995; 674: 205–217.
24. 24. GF Weber DJ Waxman 1993 Activation of the anti-cancer drug ifosfamide by rat liver microsomal P450 enzymes Biochem Pharmacol 45 1685 1694 1:CAS:528:DyaK3sXktF2qs78%3D 8484807 10.1016/0006-2952(93)90310-S Weber GF, Waxman DJ. Activation of the anti-cancer drug ifosfamide by rat liver microsomal P450 enzymes. Biochem Pharmacol. 1993; 45: 1685–1694.
25. 25. HB Waynforth PA Flecknell 1992 Experimental and Surgical Technique in the Rat 2nd ed. Academic Press London 279 279 Waynforth HB, Flecknell PA. In: Experimental and Surgical Technique in the Rat. 2nd ed. London: Academic Press; 1992: 279.
26. 26. MG Wientjes E Mukherji JL-S Au 1992 Nonlinear disposition of intravenous 2′,3′-dideoxyinosine in rats Pharm Res 9 1070 1075 1:CAS:528:DyaK38Xls1egsbs%3D 1409380 10.1023/A:1015866714224 Wientjes MG, Mukherji E, Au JL-S. Nonlinear disposition of intravenous 2′,3′-dideoxyinosine in rats. Pharm Res. 1992; 9: 1070–1075.
27. 27. MA Robinson R Mehvar 1996 Enantioselective distribution of verapamil and norverapamil into human and rat erythrocytes: the role of plasma protein binding Biopharm Drug Dispos 17 577 587 1:CAS:528:DyaK28XmtFSltbY%3D 8894116 10.1002/(SICI)1099-081X(199610)17:7<577::AID-BDD984>3.0.CO;2-P Robinson MA, Mehvar R. Enantioselective distribution of verapamil and norverapamil into human and rat erythrocytes: the role of plasma protein binding. Biopharm Drug Dispos. 1996; 17: 577–587.
28. 28. Gibson G, Skett P. Techniques and experiments illustrating drug metabolism. In: Introduction to Drug Metabolism. 2nd ed. Chapman and Hall; 1994: 217–258.
29. 29. JJ Zheng KK Chan F Muggia 1994 Preclinical pharmacokinetics and stability of isophosphoramide mustard Cancer Chemother Pharmacol 33 391 479 1:CAS:528:DyaK2cXls12lsLw%3D 8306413 10.1007/BF00686268 Zheng JJ, Chan KK, Muggia F. Preclinical pharmacokinetics and stability of isophosphoramide mustard. Cancer Chemother Pharmacol. 1994; 33: 391–479.
30. 30. KK Chan 1982 A simple integrated method for drug and derived metabolite kinetics: an application of the statical moment theory Drug Metab Disp 10 474 479 1:CAS:528:DyaL38XlvFalt74%3D Chan KK. A simple integrated method for drug and derived metabolite kinetics: an application of the statical moment theory. Drug Metab Disp. 1982; 10: 474–479.
31. 31. Wang JJ-H. Stereoselective pharmacokinetics and drug metabolism of ifosfamide in the rat. PhD dissertation, University of Southern California, 1995.
32. 32. L Yu DJ Waxman 1996 Role of cytochrome P450 in oxazaphosphorine metabolism, deactivation via N-dechloroethylation and activation via 4-hydroxylation catalyzed by distinct subsets of rat liver cytochrome P450 Drug Metab Dispos 24 1254 1262 1:CAS:528:DyaK28XntVOisbw%3D 8937861 Yu L, Waxman DJ. Role of cytochrome P450 in oxazaphosphorine metabolism, deactivation via N-dechloroethylation and activation via 4-hydroxylation catalyzed by distinct subsets of rat liver cytochrome P450. Drug Metab Dispos. 1996; 24: 1254–1262.